What does prescription reimbursement liabilities mean?

This represents short-term obligations owed to pharmacies or other network participants resulting from prescription transactions processed through the platform. It reflects the company's role as an intermediary in the payment flow between consumers and healthcare providers. Managing this liability is critical for maintaining healthy relationships with pharmacy networks and ensuring operational liquidity.

GoodRx Holdings, Inc. GDRX Prescription reimbursement liabilities

Prescription reimbursement liabilities at other companies

CignaCI

$25.76B-9.9%

InnovAge Holdings, Inc.INNV

$16.32M-5.8%

XER

Xeris Biopharma Holdings, Inc.XERS

$45.49M+48.0%

OrganonOGN

$1.42B+0.8%

HRO

HarrowHROW

$51.13M+64.1%

IBT

IbottaIBTA

$106.29M+22.8%

Other financials

Income statement

See full

Revenue$194.0M-4.4%

Gross profit$173.9M-8.3%

Operating income$14.0M-40.1%

Net income$1.2M-89.4%

EPS (diluted)$0.00-100%

Balance sheet

See full

Cash & equivalents$235.7M-21.7%

Total debt$541.4M0.0%

Total equity$622.0M-4.9%

Total assets$2.0B+56.0%

Cash flow

See full

Operating cash flow$11.8M+25.8%

CapEx$1.1M+700%

Free cash flow$10.7M+15.4%

Valuation

See full

Market cap$911.04M-44.5%

Enterprise value$1.22B-35.4%

P/E44.3×-13.4×

P/S1.2×-0.9×

Profitability

See full

Gross margin91.8%-2.0pp

Operating margin9.9%-0.3pp

Net margin2.6%-1.0pp

FCF margin21%+2.3pp

Returns & leverage

See full

Return on equity3.2%-1.2pp

Debt / equity0.9×0.0×

Current ratio1.5×-3.8×

Where this comes from

Reported directly by GoodRx Holdings, Inc. in its filing.

Tagged under the XBRL concept gdrx:PrescriptionReimbursementLiabilitiesCurrent.

The official record: GoodRx Holdings, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about GoodRx Holdings, Inc.'s prescription reimbursement liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is GoodRx Holdings, Inc.'s prescription reimbursement liabilities?: GoodRx Holdings, Inc. (GDRX) reported prescription reimbursement liabilities of $750.98M in Q1 2026.
What does prescription reimbursement liabilities mean?: This represents short-term obligations owed to pharmacies or other network participants resulting from prescription transactions processed through the platform. It reflects the company's role as an intermediary in the payment flow between consumers and healthcare providers. Managing this liability is critical for maintaining healthy relationships with pharmacy networks and ensuring operational liquidity.